The goal of this research program is develop a sensitive assay of gene expression patterns which can be used on a variety of scales to study aspects of gene expression in disease, development, physiology and pharmacology. The approach, known as RAGE (Restriction Analysis of Gene Expression), is based on degenerate primer PCR of gene families followed by a restriction endonuclease analysis which allows rapid identification and quantitation of numerous individual genes simultaneously. The RAGE technique is complementary to other current gene expression methods, such as microarray hybridization, SAGE, differential display and RDA; sharing some of the strengths of each of these approaches. Alterations in gene expression due to genomic deletions, translocations, amplifications or drug/hormone treatments, or changes in the transcriptional state of small samples of cells can be easily detected using this approach. The project will expand the range of this technique to numerous gene families involved in signal transduction and cell regulation, such as protein tyrosine kinases, serine/threonine kinases, tyrosine phosphatases, proteases, GTPases, receptor families, and transcription factor families. Additionally, fluorescence based technologies will be applied to increase both the number of gene families and the number of samples which can be easily analyzed. Along with the development of the technology, the project will provide two useful types of datasets of the research community. The first are datasets of restriction fragment lengths for the various gene families necessary to interpret experimental results. The second are datasets of gene expression patterns measured by RAGE on a set of reference samples: the NCI 60 human cancer cell lines being characterize for drug susceptibility. These profiles of gene expression could provide valuable diagnostic and prognostic markers for many types of common human cancers as well as useful information for drug development and evaluation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA082073-04
Application #
6377277
Study Section
Special Emphasis Panel (ZCA1-RLB-Y (M1))
Project Start
1998-09-30
Project End
2003-07-31
Budget Start
2001-08-01
Budget End
2003-07-31
Support Year
4
Fiscal Year
2001
Total Cost
$173,016
Indirect Cost
Name
University of California Davis
Department
Type
Organized Research Units
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Wu, Yi-Mi; Robinson, Dan R; Kung, Hsing-Jien (2004) Signal pathways in up-regulation of chemokines by tyrosine kinase MER/NYK in prostate cancer cells. Cancer Res 64:7311-20
Lee, Li-Fen; Louie, Maggie C; Desai, Sonal J et al. (2004) Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK. Oncogene 23:2197-205
Xia, Liang; Robinson, Dan; Ma, Ai-Hong et al. (2002) Identification of human male germ cell-associated kinase, a kinase transcriptionally activated by androgen in prostate cancer cells. J Biol Chem 277:35422-33
Robinson, D R; Wu, Y M; Lin, S F (2000) The protein tyrosine kinase family of the human genome. Oncogene 19:5548-57